SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-029459
Filing Date
2021-11-22
Accepted
2021-11-22 07:40:20
Documents
14
Period of Report
2021-11-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36676
2 ex99-1.htm EX-99.1 26518
3 ex99-1_001.jpg GRAPHIC 6747
  Complete submission text file 0001493152-21-029459.txt   252172

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prvb-20211122.xsd EX-101.SCH 3040
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prvb-20211122_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prvb-20211122_pre.xml EX-101.PRE 22369
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3612
Mailing Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701
Business Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701 908-428-9136
Provention Bio, Inc. (Filer) CIK: 0001695357 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38552 | Film No.: 211430165
SIC: 2834 Pharmaceutical Preparations